The scientists hope that a combination of insights from pathological genetic mutations and general characteristics of the patients with the disease and their physicians will be useful for the management of CVD.
One of the contributing factors is a mutation in a gene known as WDR1 (cyclic MYC-containing retrotransposon gene), which plays a major role in the development of CVD.
People with the mutation we studied who had recently had heart attacks were much more likely to develop cardiovascular diseases in the future.